3D in vitro models uncover malignant cell intrinsic and extrinsic mechanisms of CAR-T cell resistance in high grade serous ovarian cancer

被引:0
|
作者
Joy, Joash Dominic
Malacrida, Beatrice
Laforets, Florian
Kotantaki, Panoraia
Maniati, Eleni
Hopkins, Sarah
Garrobo-Calleja, Ianire
Gautrot, Julien
Balkwill, Frances
机构
关键词
D O I
10.1158/1538-7445.AM2023-4576
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4576
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Human 3D ovarian cancer models reveal malignant cell intrinsic and extrinsic factors that influence CAR-T cell activity
    Joy, Joash D.
    Malacrida, Beatrice
    Laforets, Florian
    Kotantaki, Panoraia
    Maniati, Eleni
    Manchanda, Ranjit
    Hopkins, Sarah
    Garrobo-Calleja, Ianire
    Annibaldi, Alessandro
    Gautrot, Julien
    Balkwill, Frances R.
    CANCER RESEARCH, 2024, 84 (05)
  • [2] Human 3D Ovarian Cancer Models Reveal Malignant Cell-Intrinsic and -Extrinsic Factors That Influence CAR T-cell Activity
    Joy, Joash D.
    Malacrida, Beatrice
    Laforets, Florian
    Kotantaki, Panoraia
    Maniati, Eleni
    Manchanda, Ranjit
    Annibaldi, Alessandro
    Hopkins, Sarah
    Garrobo-Calleja, Ianire
    Gautrot, Julien
    Balkwill, Frances R.
    CANCER RESEARCH, 2024, 84 (15) : 2432 - 2449
  • [3] 3D IN VITRO TUMOR MICROENVIRONMENT MODELS FOR SCREENING CAR-T CELL THERAPY EFFICACY
    Xue, Bin
    Vermond, Sophie
    Herbrand, Ulrike
    Harris, David
    Moiset, Gemma
    Hribar, Kolin
    Schuler, Julia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A314 - A314
  • [4] Building in vitro 3D human multicellular models of high-grade serous ovarian cancer
    Malacrida, Beatrice
    Pearce, Oliver M. T.
    Balkwill, Frances R.
    STAR PROTOCOLS, 2022, 3 (01):
  • [5] The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models
    Tadic, Vanja
    Zhang, Wei
    Brozovic, Anamaria
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (01):
  • [6] Differential responses and mechanisms of resistance to cediranib in high grade serous ovarian cancer mouse models.
    Gopinathan, Ganga
    Maniati, Eleni
    Berlato, Chiara
    Lakhani, Anissa
    Pergum, Colin
    Laforets, Florian
    Szabova, Ludmila
    Balkwill, Frances
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Microfluidic approach to study T and CAR-T confined and 3D cell migration
    Zhou, Jack Zhang
    Onate Salafranca, Carmen
    Movilla Meno, Nieves
    Jose Gomez-Benito, Maria
    Enrique Guerrero, Pedro
    Pardo Jimeno, Julian
    Manuel Garcia-Aznar, Jose
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 342 - 342
  • [8] Evaluating CAR-T Cell Therapy in a Hypoxic 3D Tumor Model
    Ando, Yuta
    Siegler, Elizabeth L.
    Ta, Hoang P.
    Cinay, Gunce E.
    Zhou, Hao
    Gorrell, Kimberly A.
    Au, Hannah
    Jarvis, Bethany M.
    Wang, Pin
    Shen, Keyue
    ADVANCED HEALTHCARE MATERIALS, 2019, 8 (05)
  • [9] LGR5 CAR-T cells: A novel potential treatment against high grade serous ovarian cancer.
    Wang, Wanqi
    Bandara, Veronika
    Lokman, Noor
    Napoli, Silvana
    Gundsambuu, Batjargal
    Oehler, Martin
    Barry, Simon C.
    Ricciardelli, Carmela
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Chimeric antigen receptor T (CAR-T) cell therapy with intrinsic PD-1 blocking for ovarian cancer
    Ukita, Masayo
    Hamanishi, Junzo
    Murakami, Ryusuke
    Abiko, Kaoru
    Baba, Tsukasa
    Mandai, Masaki
    CANCER SCIENCE, 2018, 109 : 335 - 335